{"id":"NCT01503021","sponsor":"Rockwell Medical Technologies, Inc.","briefTitle":"Safety Study of Soluble Ferric Pyrophosphate (SFP) in Dialysate in CKD Patients Receiving Chronic Hemodialysis","officialTitle":"A Randomized, Double-Blinded, Placebo-Controlled, Crossover, Multicenter Phase III Safety Study of Soluble Ferric Pyrophosphate (SFP) in Dialysate in Chronic Kidney Disease Patients Receiving Chronic Hemodialysis","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2011-11","primaryCompletion":"2014-01","completion":"2014-01","firstPosted":"2012-01-02","resultsPosted":"2015-04-21","lastUpdate":"2016-10-25"},"enrollment":718,"design":{"allocation":"RANDOMIZED","model":"CROSSOVER","masking":"TRIPLE","primaryPurpose":"TREATMENT"},"conditions":["End Stage Renal Disease","Chronic Kidney Disease"],"interventions":[{"type":"DRUG","name":"SFP","otherNames":["Soluble ferric pyrophosphate"]},{"type":"OTHER","name":"Placebo","otherNames":["Standard liquid bicarbonate concentrate"]}],"arms":[{"label":"SFP/Placebo","type":"OTHER"},{"label":"Placebo/SFP","type":"OTHER"}],"summary":"The purpose of the parent study is to assess the short-term safety and tolerability of soluble ferric pyrophosphate (SFP) in dialysate administered to a large number of representative adult chronic kidney disease patients on hemodialysis (CKD-HD).\n\nThe purpose of the extension study is to assess the long-term safety and tolerability of SFP.","primaryOutcome":{"measure":"Incidence of Treatment-emergent Adverse Events","timeFrame":"Up to 7 weeks for the Parent (Crossover) Study and up to 53 weeks for Extension Study","effectByArm":[{"arm":"Soluble Ferric Pyrophosphate","deltaMin":31.6,"sd":null},{"arm":"Placebo","deltaMin":35.1,"sd":null},{"arm":"Open-label Soluble Ferric Pyrophosphate","deltaMin":95.1,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":31,"countries":["United States","Canada"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":30,"n":693},"commonTop":["Procedural hypotension","Nausea","Diarrhoea","Arteriovenous fistula site complication","Haemodialysis-induced symptom"]}}